Narcolepsy with cataplexy is a severely disabling disorder very often arising in childhood. Data on neuropsychological impairment in children are scant. We administered standardized neuropsychological tests to 13 children with narcolepsy with cataplexy. Overall, our patients displayed multiple patterns of cognitive and behavioral dysfunction, and often academic failure (7 cases out of 13). All children had a normal full intelligence quotient (IQ), but 3 patients presented a significantly higher and 2 a significantly lower Verbal IQ compared to Performance IQ, respectively. Mean sleep latency was significantly correlated (P < .05) to alertness functions. Eight patients displayed behavioral problems: emotional symptoms and conduct problems prevailed. Childhood narcolepsy with cataplexy represents a risk factor for subtle and heterogeneous cognitive impairments potentially resulting in academic failure, despite the normal IQ. These children also have a certain psychopathological risk. All this seems to be at least partially detached from the direct effects of daytime sleepiness.
American Academy of Sleep Medicine. International Classification of Sleep Disorders, 2nd ed.: Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
StoresGMontgomeryPWiggsL. The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics. 2006;118:e1116–e1123.
7.
PlazziGPizzaFPalaiaV. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain. 2011;134(pt 12):3480–3492.
8.
LucaGHaba-RubioJDauvilliersY. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res. 2013;22:482–495.
9.
ChallamelMJMazzolaMENevsimalovaS. Narcolepsy in children. Sleep. 1994;17(8 suppl):S17–S20.
10.
LongstrethWTJrKoepsellTDTonTG. The epidemiology of narcolepsy. Sleep. 2007;30:13–26.
11.
de LeceaLKilduffTSPeyronC. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998;95:322–327.
12.
SakuraiTAmemiyaAIshiiM. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573–585.
13.
PeyronCFaracoJRogersW. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6:991–997.
14.
ThannickalTCMooreRYNienhuisR. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27:469–474.
15.
MignotELinXArrigoniJ. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep. 1994;17(8 suppl):S60–S67.
16.
PartinenMSaarenpää-HeikkiläOIlveskoskiI. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 2012;7:e33723.
17.
KeamSWalkerMC. Therapies for narcolepsy with or without cataplexy: evidence-based review. Curr Opin Neurol. 2007;20:699–703.
18.
MignotEJ. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics. 2012;9:739–752.
FuldaSSchulzH. Cognitive dysfunction in sleep disorders. Sleep Med Rev. 2001;5:423–445.
21.
NaumannABellebaumCDaumI. Cognitive deficits in narcolepsy. J Sleep Res. 2006;15:329–338.
22.
DelazerMHöglBZamarianL. Executive functions, information sampling, and decision making in narcolepsy with cataplexy. Neuropsychology. 2011;25:477–487.
23.
HoodBBruckD. A comparison of sleep deprivation and narcolepsy in terms of complex cognitive performance and subjective sleepiness. Sleep Med. 2002;3:259–266.
24.
BroughtonWABroughtonRJ. Psychosocial impact of narcolepsy. Sleep. 1994;17(8 suppl):S45–S49.
25.
BruckD. The impact of narcolepsy on psychological health and role behaviours: negative effects and comparisons with other illness groups. Sleep Med. 2001;2:437–446.
26.
AchenbachTMRescorlaLA. Manual for the ASEBA School-Age Forms and Profiles. Burlington, VT: University of Vermont, Research Centre for Children, Youth, and Families; 2001.
27.
LittnerMRKushidaCWiseM. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 2005;28:113–121.
28.
GoodmanR. The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry. 1997;38:581–586.
29.
StoneLLOttenREngelsRC. Psychometric properties of the parent and teacher versions of the strengths and difficulties questionnaire for 4- to 12-year-olds: a review. Clin Child Fam Psychol Rev. 2010;13:254–274.
30.
ValleyVBroughtonR. Daytime performance deficits and physiological vigilance in untreated patients with narcolepsy-cataplexy compared to controls. Rev Electroencephalogr Neurophysiol Clin. 1981;11:133–139.
31.
RivaD. Le basi neurobiologiche dei disordini dell'apprendimento. Gior Neuropsich Età Evol. 1999;19:28–38.
